ZA200807682B - Novel formulations - Google Patents

Novel formulations

Info

Publication number
ZA200807682B
ZA200807682B ZA200807682A ZA200807682A ZA200807682B ZA 200807682 B ZA200807682 B ZA 200807682B ZA 200807682 A ZA200807682 A ZA 200807682A ZA 200807682 A ZA200807682 A ZA 200807682A ZA 200807682 B ZA200807682 B ZA 200807682B
Authority
ZA
South Africa
Prior art keywords
novel formulations
formulations
novel
Prior art date
Application number
ZA200807682A
Inventor
Capecchi John
Stefely James
Riley Trevor
Original Assignee
3M Innovative Properties Co Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38523271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200807682(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 3M Innovative Properties Co Glaxo Group Ltd filed Critical 3M Innovative Properties Co Glaxo Group Ltd
Publication of ZA200807682B publication Critical patent/ZA200807682B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
ZA200807682A 2006-03-22 2008-09-05 Novel formulations ZA200807682B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78463406P 2006-03-22 2006-03-22

Publications (1)

Publication Number Publication Date
ZA200807682B true ZA200807682B (en) 2009-11-25

Family

ID=38523271

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200807682A ZA200807682B (en) 2006-03-22 2008-09-05 Novel formulations

Country Status (18)

Country Link
EP (1) EP2012797A2 (en)
JP (1) JP2009530419A (en)
KR (1) KR20080110854A (en)
CN (1) CN101415428A (en)
AR (1) AR060039A1 (en)
AU (1) AU2007226899A1 (en)
BR (1) BRPI0708798A2 (en)
CA (1) CA2646236A1 (en)
CR (1) CR10261A (en)
EA (1) EA200801854A1 (en)
IL (1) IL193723A0 (en)
MA (1) MA30328B1 (en)
MX (1) MX2008011967A (en)
NO (1) NO20083760L (en)
PE (1) PE20080124A1 (en)
TW (1) TW200803870A (en)
WO (1) WO2007109698A2 (en)
ZA (1) ZA200807682B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2400950B1 (en) * 2009-02-26 2019-05-22 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69413955T2 (en) * 1993-03-17 1999-04-01 Minnesota Mining & Mfg AEROSOL COMPOSITION CONTAINING A DERIVATIVE DERIVATIVE FROM ESTER, AMID OR MERCAPTOESTER
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
AU2001276497B2 (en) * 2000-08-05 2005-04-07 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents

Also Published As

Publication number Publication date
NO20083760L (en) 2008-12-17
EP2012797A2 (en) 2009-01-14
MA30328B1 (en) 2009-04-01
WO2007109698A3 (en) 2008-12-18
CR10261A (en) 2008-11-26
TW200803870A (en) 2008-01-16
BRPI0708798A2 (en) 2011-06-14
CA2646236A1 (en) 2007-09-27
AU2007226899A1 (en) 2007-09-27
IL193723A0 (en) 2009-08-03
CN101415428A (en) 2009-04-22
KR20080110854A (en) 2008-12-19
EA200801854A1 (en) 2009-04-28
WO2007109698A2 (en) 2007-09-27
MX2008011967A (en) 2009-01-14
AR060039A1 (en) 2008-05-21
JP2009530419A (en) 2009-08-27
PE20080124A1 (en) 2008-04-21

Similar Documents

Publication Publication Date Title
GB2435419B (en) Formulations
EP2046930A4 (en) Rhamnolipid-based formulations
GB0605780D0 (en) Formulations
GB2424581B (en) Formulations
GB0711656D0 (en) Formulations
GB0716385D0 (en) Formulations
EP1909584A4 (en) Prenylflavonoid formulations
GB0712884D0 (en) Formulations
GB0618697D0 (en) Formulations
GB0505569D0 (en) Formulations
GB0615108D0 (en) Novel formulations
GB0711957D0 (en) Formulations
GB0809979D0 (en) Formulations
GB0610336D0 (en) Formulations
GB0810232D0 (en) Formulations
GB0718404D0 (en) Formulations
ZA200807682B (en) Novel formulations
GB0705179D0 (en) Formulations
GB0610570D0 (en) Novel formulation
GB0618691D0 (en) Formulations
GB0603380D0 (en) Formulations
GB0603981D0 (en) Tissue-adhesive formulations
GB0611519D0 (en) Formulations
GB0623791D0 (en) Formulations
GB0713886D0 (en) Formulations